Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02500407
Brief Title: A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

First Submitted : July 14, 2015
First Submitted that Met QC Criteria : July 14, 2015
First Posted : July 16, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 9, 2021
Last Update Posted : June 11, 2021 (Estimate)